More About Neera Tanden
We should require drug companies to either reinvest a minimum percentage of revenues in research and development or contribute the shortfall to the National Institutes of Health, and this will also cause drug prices to fall.
Surveys in recent years have repeatedly shown that Americans are concerned about the cost of prescription drugs. But concern turned to outrage this month when a pharmaceutical company jacked up the price of a generic drug called Daraprim from $13.50 to $750. Experts weigh in.